Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
18.04. | Calidi Biotherapeutics, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
16.04. | Why Calidi Biotherapeutics (CLDI) Shares Are Down Over 50% | 1 | Benzinga.com | ||
16.04. | Why Is Calidi Biotherapeutics (CLDI) Stock Down 51% Today? | 1 | InvestorPlace | ||
16.04. | Calidi Biotherapeutics slumps 54%, prices $6.1M equity | 1 | Seeking Alpha | ||
08.04. | Calidi Biotherapeutics, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
01.04. | Calidi Biotherapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
30.03. | Calidi Biotherapeutics, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
21.03. | Calidi Biotherapeutics stock target slashed to $2 by H.C. Wainwright | 2 | Investing.com | ||
15.03. | Calidi Biotherapeutics, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
15.03. | Calidi Biotherapeutics reports Q4 results | 1 | Seeking Alpha | ||
15.03. | Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results | 106 | Business Wire | SAN DIEGO--(BUSINESS WIRE)--Calidi Biotherapeutics Inc. (NYSE American: CLDI) ("Calidi"), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today reported... ► Artikel lesen | |
12.03. | Calidi Biotherapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
28.02. | Calidi Biotherapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
12.02. | Calidi Biotherapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
07.02. | Calidi Biotherapeutics files to sell 10M shares, 10M warrants | - | Seeking Alpha | ||
07.02. | Calidi Biotherapeutics, Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
01.02. | Calidi Biotherapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
29.01. | Calidi Biotherapeutics, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
16.01. | Calidi Biotherapeutics, Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
08.01. | Calidi Biotherapeutics, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MORPHOSYS | 65,65 | -3,24 % | EQS-PVR: MorphoSys AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: MorphoSys AG
MorphoSys AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
22.04.2024 / 16:00 CET/CEST
Veröffentlichung... ► Artikel lesen | |
EVOTEC | 9,625 | +4,22 % | Aufholjagd BioTech 2024 - jetzt positionieren! Bayer, BioNTech, Defence Therapeutics, Evotec, BioNxt und Vidac Pharma im Fokus | BioTech-Investoren haben im Jahr 2024 bislang noch keine große Party feiern können. Das blieb eher den Spekulanten in den Sektoren Künstliche Intelligenz und Rüstung vorbehalten. Doch nun neigen sich... ► Artikel lesen | |
QIAGEN | 39,145 | +0,99 % | Biotech Report: Sektor fester - Evotec und Qiagen können zulegen | (shareribs.com) Frankfurt / New York 22.04.2024 - Biotech-Aktien verzeichneten zum Wochenauftakt im deutschen Handel Kursgewinne. Gesucht waren unter anderem Evotec und Qiagen. Auch an der Wall Street... ► Artikel lesen | |
BIONTECH | 83,85 | +1,76 % | UNGLAUBLICHE Sondermeldung bei BioNtech Aktie: DAS erwischt Anleger heute eiskalt. Dringend lesen und reagieren! | ||
JANUX THERAPEUTICS | 54,92 | +15,89 % | Aktien New York: Dow erholt sich vor Start in die Berichtssaison | NEW YORK (dpa-AFX) - Die US-Aktienmärkte haben sich am Donnerstag im Handelsverlauf von ihrer anfänglichen Schwächephase erholt. Der Dow Jones Industrial notierte zuletzt 0,12 Prozent im Plus bei 38... ► Artikel lesen | |
CULLINAN THERAPEUTICS | 27,960 | +10,51 % | Cullinan Therapeutics, Inc.: Cullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financial Officer | CAMBRIDGE, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on modality-agnostic targeted therapies, today announced the appointment... ► Artikel lesen | |
RECURSION PHARMACEUTICALS | 8,220 | +1,23 % | Recursion Pharmaceuticals' Options Frenzy: What You Need to Know | ||
CABALETTA BIO | 10,560 | -4,09 % | Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update | - First patient dosed with CABA-201 in the RESET (REstoring SElf-Tolerance) clinical trial program - - Initial clinical data from each of the first patients in the RESET-Myositis and RESET-SLE trials... ► Artikel lesen | |
SPRINGWORKS THERAPEUTICS | 46,340 | +1,78 % | SpringWorks Therapeutics, Inc.: SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting | ||
IMMUNOVANT | 27,160 | -0,04 % | Should You Hold Immunovant (IMVT)? | ||
ARVINAS | 31,830 | -1,73 % | Arvinas Inc.: Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer | NEW HAVEN, Conn., April 24, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today... ► Artikel lesen | |
DAY ONE BIOPHARMACEUTICALS | 16,480 | +24,75 % | Day One Biopharmaceuticals, Inc.: Day One's OJEMDA (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor | First and only FDA-approved type II RAF inhibitor for patients with relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or BRAF V600 mutation RAPNO LGG overall response rate... ► Artikel lesen | |
ZYVERSA THERAPEUTICS | 5,610 | +14,72 % | What's Going On With ZyVersa Stock? | ||
BEAM THERAPEUTICS | 22,280 | +4,31 % | Expert Ratings For Beam Therapeutics | ||
IMMUNITYBIO | 8,314 | +21,09 % | Pre-market Movers: Abeona Therapeutics, HWH International, ImmunityBio, Hibbett, AGBA Group | NORWALK (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.55 A.M. ET).In the Green HWH International Inc. (HWH) is up over 42% at $1.83.
ImmunityBio... ► Artikel lesen |